Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 12/20 | 0.55 |
| ▸ | CYP4A11 | Q02928 | 12/20 | 0.55 |
| ▸ | F10 | P00742 | 1/20 | 0.41 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.40 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.37 |
| ▸ | FEN1 | P39748 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22968202 | 0.82 | CYP4F2 (0.56) | CYP4F2CYP4A11F10NR1H3GPR119 | |
| SCHEMBL22968107 | 0.81 | CYP4F2 (0.53) | CYP4F2CYP4A11F10NR1H3GPR119 | |
| SCHEMBL20590842 | 0.80 | P4HTM (0.47) | EGLN2 | |
| SCHEMBL19277464 | 0.76 | CYP4F2 (0.61) | CYP4F2CYP4A11F10NR1H3NR1H2 | |
| SCHEMBL20590908 | 0.73 | CYP4F2 (0.58) | CYP4F2CYP4A11F10NR1H3NR1H2 | |
| SCHEMBL19277476 | 0.71 | CYP4F2 (1.00) | CYP4F2CYP4A11 | |
| SCHEMBL22968091 | 0.71 | CYP4F2 (0.67) | CYP4F2CYP4A11 | |
| SCHEMBL19277509 | 0.70 | CYP4F2 (0.69) | CYP4F2CYP4A11 | |
| SCHEMBL19277513 | 0.70 | CYP4F2 (0.66) | CYP4F2CYP4A11 | |
| SCHEMBL22968327 | 0.69 | CYP4F2 (0.61) | CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210040062-A1 | AZOLE-SUBSTITUTED PYRIDINE COMPOUND | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2021-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040062-A1 | AZOLE-SUBSTITUTED PYRIDINE COMPOUND | CYP2F1, CYP21A2, CYP11B1 | CYP4F2 8/4885CYP4A11 13/4885F10 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.